Cite
APA Citation
Kawagishi, N., Suda, G., Onozawa, M., Kimura, M., Maehara, O., Ohara, M., Izumi, T., Umemura, M., Ito, J., Nakai, M., Sho, T., Natsuizaka, M., Morikawa, K., Ogawa, K., & Sakamoto, N. (2017). comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C. Journal of viral hepatitis, 24(12), 1098–1106. http://access.bl.uk/ark:/81055/vdc_100054254545.0x00001a